Blood and/or platelet transfusion for Blood Cancers

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Blood CancersBlood and/or platelet transfusion - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study whether blood transfusions can help improve symptoms and quality of life for hospice patients.

Eligible Conditions
  • Blood Cancers

Treatment Effectiveness

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 6 months

6 months
Proportion of subjects with improved palliative efficacy after receiving transfusions.
Proportion of subjects with improved quality of life after receiving transfusions.

Trial Safety

Trial Design

1 Treatment Group

Tranfusions and blood collection
1 of 1

Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Blood and/or platelet transfusion · No Placebo Group · N/A

Tranfusions and blood collectionExperimental Group · 2 Interventions: Blood and/or platelet transfusion, Complete blood count (CBC) collection · Intervention Types: Procedure, Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

University of OklahomaLead Sponsor
421 Previous Clinical Trials
97,086 Total Patients Enrolled
Jennifer Holter, MDPrincipal InvestigatorUniversity of Oklahoma
2 Previous Clinical Trials
73 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: